NXS2 murine neuroblastomas express increased levels of MHC class I antigens upon recurrence following NK-dependent immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 1, p. 41, doi. 10.1007/s00262-003-0435-2

By:

• Neal, Zane C.;
• Imboden, Michael;
• Rakhmilevich, Alexander L.;
• Kyung-Mann Kim;
• Hank, Jacquelyn A.;
• Surfus, Jean;
• Dixon, John R.;
• Lode, Holger N.;
• Reisfeld, Ralph A.;
• Gillies, Stephen D.;
• Sondel, Paul M.

Publication type:

Article